How a closet full of EKG machines illustrates pharma’s clinical trial cost problemnews2026-02-11T15:00:30+00:00February 11th, 2026|Endpoints News|
Moderna accuses FDA of shifting standard as agency refuses flu shot reviewnews2026-02-10T23:00:09+00:00February 10th, 2026|Endpoints News|
AbbVie, AstraZeneca lose appeal in Louisiana 340B contract pharmacy fightnews2026-02-10T20:06:24+00:00February 10th, 2026|Endpoints News|
NIH stops low-dose Xarelto arm of large stroke study due to safety concernsnews2026-02-10T19:55:14+00:00February 10th, 2026|Endpoints News|
Is AstraZeneca on track to meet its $80B revenue target?news2026-02-10T16:34:33+00:00February 10th, 2026|Endpoints News|
CSL’s Paul McKenzie out, as Gordon Naylor named interim CEOnews2026-02-10T12:21:35+00:00February 10th, 2026|Endpoints News|
With scant data, RFK Jr. credits Trump for higher European drug pricesnews2026-02-09T20:44:29+00:00February 9th, 2026|Endpoints News|
Despite FDA’s crackdown, pharma is still spending millions on adsnews2026-02-09T16:06:06+00:00February 9th, 2026|Endpoints News|
#ACTRIMS26: Roche’s MS drug fenebrutinib beats Ocrevus, cutting risk of disability progression by 12%news2026-02-09T14:15:12+00:00February 9th, 2026|Endpoints News|
Novo Nordisk sues Hims over Wegovy patent infringement, considers seeking ‘hundreds of millions’ in damagesnews2026-02-09T12:04:55+00:00February 9th, 2026|Endpoints News|
